Who has invested in GentiBio?

OrbiMed, Novartis Venture Fund, RA Capital Management are named among the investors backing GentiBio.

GentiBio Funding: $20M Raised, Seed (2020)

GentiBio funding overview

GentiBio is based in Cambridge, Massachusetts. GentiBio has raised $20M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Seed announced in January 2020. The round record for GentiBio runs through 2020; nothing later has been disclosed. Investors on record include OrbiMed, Novartis Venture Fund, RA Capital Management. 3 distinct backers are named across the disclosed rounds.

GentiBio at a glance

Total raised: $20M
Latest round: Seed
Latest round date: January 2020
Headquarters: Cambridge, Massachusetts
Notable investors: OrbiMed, Novartis Venture Fund, RA Capital Management

Frequently asked about GentiBio funding

How much has GentiBio raised?: GentiBio has raised $20M in total disclosed funding across the rounds on record.
Who has invested in GentiBio?: OrbiMed, Novartis Venture Fund, RA Capital Management are named among the investors backing GentiBio.
What was the latest GentiBio funding round?: The most recent disclosed round is a Seed, announced in January 2020.
Where is GentiBio based?: GentiBio is based in Cambridge, Massachusetts.
When did GentiBio last raise?: The last disclosed GentiBio round closed in January 2020 at Seed.

Totals shown for GentiBio aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.

GentiBio Funding: $20M Raised, Seed (2020)

GentiBio funding overview

GentiBio at a glance

Frequently asked about GentiBio funding

Companies related to GentiBio (36)

Browse related funding lists (7)